NodThera is a biotechnology company engaged in the discovery and development of new treatments for diseases driven by chronic inflammation. Its leading project is focused on developing inhibitors of the NLRP3 inflammasome for the treatment of inflammatory and neuroinflammatory diseases.
|HQ||Little Chesterford, GB||Map|
|Employees (est.) (Jun 2021)||27||(+4%)|
NodThera total Funding
NodThera latest funding size
Time since last funding
|a year ago|
|Sofinnova Partners, 5AM Ventures, Novo Ventures, Epidarex Capital, F-Prime Capital Partners, F-Prime Capital, Cowen Healthcare Investments, Sanofi Ventures|
|GBP||FY, 2017||FY, 2018|
When was NodThera founded?
NodThera was founded in 2016.
Who are NodThera key executives?
NodThera's key executives are Adam Keeney, Katina Dorton and Alan Watt.
How many employees does NodThera have?
NodThera has 27 employees.
Who are NodThera competitors?
Competitors of NodThera include Genfit, IHMA and OaCP.
Where is NodThera headquarters?
NodThera headquarters is located at Suite 8, The Mansion Chesterford Research Park, Little Chesterford.
Where are NodThera offices?
NodThera has offices in Little Chesterford, Aberdeen, Lexington and Seattle.
How many offices does NodThera have?
NodThera has 4 offices.
Receive alerts for 300+ data fields across thousands of companies